A Q3 2017 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q3 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.1B+6.7% YoY

Gross Profit

$596M53.5% margin

Operating Income

$201M18.0% margin

Net Income

$175M15.7% margin

EPS (Diluted)

$0.54

QoQ Revenue Growth

+1.1%

Cash Flow

Operating Cash Flow

$228M

Free Cash Flow

$185M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$8.3B

Total Liabilities

$3.6B

Stockholders' Equity

$4.6B

Cash & Equivalents

$2.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.0B	+6.7%
Gross Profit	$596M	$542M	+10.0%
Operating Income	$201M	$146M	+37.7%
Net Income	$175M	$124M	+41.1%

Revenue Segments

Life Sciences and Applied Markets

$531M48%

Agilent CrossLab

$386M35%

Diagnostics and Genomics

$197M18%